The use of inhaled anticholinergics in chronic obstructive pulmonary disease. Is there cause for concern of cardiovascular safety?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 1, 2009
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Administration, Inhalation (MeSH)
- Bronchodilator Agents (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Cholinergic Antagonists (MeSH)
- Humans (MeSH)
- Pulmonary Disease, Chronic Obstructive (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Risk Factors (MeSH)
- Scopolamine Derivatives (MeSH)
- Severity of Illness Index (MeSH)
- Tiotropium Bromide (MeSH)